Metrics
1 readers on Mendeley
- Title
- R289, a Dual Irak 1/4 Inhibitor, in Patients with Relapsed/Refractory (R/R) Lower-Risk Myelodysplastic Syndrome (LR-MDS): Initial Results from a Phase 1b Study
- Creators
- Guillermo Garcia-Manero - The University of Texas MD Anderson Cancer CenterYazan F Madanat - Southwestern Medical CenterMikkael A. Sekeres - Sylvester Comprehensive Cancer CenterHetty E. Carraway - Cleveland ClinicMike Cusnir - Sylvester Comprehensive Cancer CenterJames McCloskey - Hackensack University Medical CenterKiran Naqvi - University of California, IrvineGary J. Schiller - University of California, Los AngelesLucy Yan - SunesisToufigh Gordi - SunesisLisa RojkjaerLewis R. Silverman - Icahn School of Medicine at Mount Sinai
- Publication Details
- Blood, Vol.144(Supplement 1), pp.4595-4595
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991032518426702976